2003
DOI: 10.1016/s0049-3848(03)00337-2
|View full text |Cite
|
Sign up to set email alerts
|

Differential effect of the GPIIb/IIIa antagonist orbofiban on human platelet aggregate formation in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…Calcium chloride (2 mmol/l) was added to isolated rested platelets at 2 × 10 8 /l in TES/Tyrodes/BSA, and 250 μl was prewarmed to 37°C in flat‐bottomed borosilicate tubes (National Scientific, Rockwood, TN, USA; Thermo Scientific, Waltham, MA, USA) containing a cushion of 7·5% polyacrylamide (Osdoit & Rosa, 2001; Racanelli et al , 2003). Clotting was initiated by adding fibrinogen (human) (5 μl at 50 mg/ml) (Enzyme Research Laboratories) and thrombin (bovine) (250 μl at 0·2 U/ml) in TES/Tyrodes followed by brief pipetting.…”
Section: Methodsmentioning
confidence: 99%
“…Calcium chloride (2 mmol/l) was added to isolated rested platelets at 2 × 10 8 /l in TES/Tyrodes/BSA, and 250 μl was prewarmed to 37°C in flat‐bottomed borosilicate tubes (National Scientific, Rockwood, TN, USA; Thermo Scientific, Waltham, MA, USA) containing a cushion of 7·5% polyacrylamide (Osdoit & Rosa, 2001; Racanelli et al , 2003). Clotting was initiated by adding fibrinogen (human) (5 μl at 50 mg/ml) (Enzyme Research Laboratories) and thrombin (bovine) (250 μl at 0·2 U/ml) in TES/Tyrodes followed by brief pipetting.…”
Section: Methodsmentioning
confidence: 99%
“…Recently presented data concerning orbofiban showed that, after in vitro stimulation, large platelet aggregates were blocked, but that small, procoagulant aggregates increased three‐ to sixfold. The data would explain the prothrombotic effects seen in some large trials with oral GP IIb/IIIa antagonists (51). Further, Schwarz et al (52) demonstrated for eptifibatide and physiologic concentrations of fibrinogen a persistence of the GP IIb/IIIa blocker‐induced conformation after fiban dissociation and a partial binding of fibrinogen and the activation‐specific mAb PAC‐1.…”
Section: Discussionmentioning
confidence: 99%